Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone and ropivacaine for lumbar muscle block in inguinal hernia repair
NCT06218160Completed
- Sponsor
- The Second Hospital of Jilin University
- Start
- Nov 2022
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Randomised trial of hydromorphone in postoperative pain, sponsored by The Second Hospital of Jilin University. Primary endpoint: Postoperative pain intensity at 48 hours. Started Nov 2022; status: completed.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06218160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218160.